New BBI Solutions Novarum Feature to Support Covid-19 Certificates
BBI Solutions' patented Novarum technology transforms a smartphone into a covid-19 diagnostics test reader.
Category: Covid 19
Covid 19
Latest
Covid 19
Latest
FDA Grants EUA for Machine Learning-Based Covid-19 Screening Device
The armband with embedded light sensors and a small computer processor is a machine learning-based covid-19 non-diagnostic screening device that identifies certain biomarkers.
Covid 19
Latest
Acupath Guarantees 24-Hour In-Lab Turnaround Time for Covid-19 PCR Results
Acupath Laboratories will meet covid-19 PCR in-lab turnaround time of 24 hours or less for all electronically ordering direct bill customers, or the test fee will be waived.
Seegene Submits Allplex SARS-CoV-2/FluA/FluB/RSV Assay for FDA EUA
The real-time RT-PCR assay from Seegene differentiates influenza A and B, RSV, and three different target genes of covid-19.
Read More
AMP: Actions the US Must Take Today to Detect, Contain, and Slow the Spread of New Highly Transmissible Covid-19 Variants
“If we can work together to strengthen our collaborations, ensure access to resources, and provide adequate funding, we will be in a much better position to respond to not only this current pandemic but all future outbreaks.”—Frederick S. Nolte, PhD
Read More
NIH Launches New Covid-19 Test Assessment Tool
New web-based platform, developed with NIH funding, will aid in monitoring emerging SARS-CoV-2 variants and the performance of diagnostic tests.
Read More
Aptamer Group, Mologic Partner to Develop Covid-19 Rapid Antigen Test
The partnership will work toward CE marking of Aptamer Group’s AptaDx SARS-CoV-2 lateral flow rapid antigen test for professional use, to detect the SARS-CoV-2 spike protein antigen in anterior nasal swabs.
Read More
One Year in Review
What “silver linings” has the pandemic response brought to you and your lab? What changes have occurred, for better or for worse, where you work?
Read More
How the US Pandemic Response Went Wrong—and What Went Right—during a Year of Covid
Scientific American takes an in-depth look at the United States’ mistakes—including sidelining experts and flawed testing—and successes in responding to the covid-19 crisis.
Read More
EUA and CE Mark for Luminex’s Expanded NxTAG Respiratory Panel Test to Include Covid-19
The new panel includes SARS-CoV-2 among 19 viral and two bacterial common respiratory pathogens.
Read More
FDA Permits Marking of First Covid-19 Diagnostic Using the De Novo Review Pathway
The BioFire Respiratory Panel 2.1 is the first SARS-CoV-2 diagnostic that will be permitted to be marketed beyond the public health emergency.
Read More
FDA Offers Serology EUA Templates for Test Developers
The templates offer recommendations on what to include in emergency use authorization requests or pre-EUA submissions for serology tests.
Read More
Biden Administration to Invest More Than $12 Billion to Expand Covid-19 Testing
HHS will invest $10 billion to ramp up screening testing to help schools reopen and $2.25 billion to scale up testing in underserved populations, and provide new guidance on asymptomatic screening testing in schools, workplaces, and congregate settings.
Read More
Diaago, Mawi DNA Technologies Partner to Provide Customizable Solutions with iSwab
The companies’ goal is to improve laboratory workflow/automation for covid-19 testing, sample storage, and biobanking.
Read More
Oxford University Hospital Deploys Sight Olo Analyzer for Covid Screening
The machine vision-based blood analyzer is part of an assessment of the AI-based ‘CURIAL’ test to rapidly screen for covid-19 in patients arriving in emergency departments.
Read More
FDA Warns of Potential for False Positives with Roche Cobas SARS-CoV-2 and Influenza Test
Roche Molecular Systems’ cobas SARS-CoV-2 and Influenza A/B Nucleic Acid Test is for use on the cobas Liat System. The false positive results may be related to two issues observed by Roche.
Read More
Rutgers Develops Rapid Test to Detect New Emerging Covid-19 Variants
Researchers have designed a new rapid test that can detect all three of the rapidly spreading variants of covid-19 in a little over one hour.
Read More
Covid-19 Testing Supply Shortages Disrupt 45% of Laboratories, CAP Survey Shows
Respondents reported continued difficulties acquiring covid-19 testing supplies, such as reagents (45%) and pipette tips (30%), within the last three months.
Read More